Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine

Summary

Chikungunya vaccine is an inactivated virus vaccine. There will be three study arms and subjects will be vaccinated in a dose escalation manner.In each arm, vaccine will be administered on Day 1, Day 29, and Day 57. Vaccine will be administered through intramuscular route.

Timeline

Start

2017-04-17

Primary completion

2018-01-30

Completion

2018-07-30

Drugs

Indications